Fatigue
Showing NaN - NaN of 19
Metastatic Cancers, Fatigue Trial in Houston (Psychoeducational Intervention, Open Label Placebo, Psychoeducational
Not yet recruiting
- Metastatic Cancers
- Fatigue
- Psychoeducational Intervention
- +2 more
-
Houston, TexasMD Anderson Cancer Centerr
Oct 10, 2023
NSCLC, Pancreatic Cancer, Colorectal Cancer Trial in Canada, United States (PF-06946860, Placebo for PF-06946860)
Completed
- Non-small Cell Lung Cancer
- +9 more
- PF-06946860
- Placebo for PF-06946860
-
Little Rock, Arkansas
- +32 more
Dec 12, 2022
Sleep, Fatigue, Anxiety Trial in Houston (Cognitive Behavior Therapy, Bright Light Therapy, Methylphenidate)
Not yet recruiting
- Sleep
- +4 more
- Cognitive Behavior Therapy
- +3 more
-
Houston, TexasMD Anderson Cancer Center
Jul 25, 2022
COVID-19, Muscle Weakness, Muscle Pain Trial in Houston (Electrical Stimulation - Active, Electrical Stimulation - Placebo)
Recruiting
- COVID-19
- +3 more
- Electrical Stimulation - Active
- Electrical Stimulation - Placebo
-
Houston, Texas
- +1 more
Jun 23, 2022
Advanced Malignant Tumor, Fatigue, Metastatic Malignant Tumor Trial in Houston (drug, behavioral, other)
Active, not recruiting
- Advanced Malignant Neoplasm
- +4 more
- Dexamethasone
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Mar 3, 2022
Ann Arbor Stage II Grade 1 Follicular Lymphoma, Ann Arbor Stage II Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 1
Active, not recruiting
- Ann Arbor Stage II Grade 1 Follicular Lymphoma
- +12 more
- Lenalidomide
- Obinutuzumab
-
Houston, TexasM D Anderson Cancer Center
Feb 18, 2022
Fatigue Trial in Houston (Methylphenidate, Fatigue Evaluations)
Completed
- Fatigue
- Methylphenidate
- Fatigue Evaluations
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 3, 2022
Fatigue, Cancer Trial in Houston (Methylphenidate, Placebo (Sugar Pill))
Completed
- Fatigue
- Cancer
- Methylphenidate
- Placebo (Sugar Pill)
-
Houston, TexasM D Anderson Cancer Center
Dec 16, 2021
Fatigue, Solid Tumor Trial in Puerto Rico, South Africa, United States (methylphenidate HCl, quality-of-life assessment)
Completed
- Fatigue
- Unspecified Adult Solid Tumor, Protocol Specific
- methylphenidate hydrochloride
- quality-of-life assessment
-
Scottsdale, Arizona
- +58 more
Oct 29, 2020
Chronic Lymphocytic Leukemia, Fatigue, Fever Trial in Houston (Lenalidomide, Ofatumumab)
Completed
- Chronic Lymphocytic Leukemia
- +9 more
- Lenalidomide
- Ofatumumab
-
Houston, TexasM D Anderson Cancer Center
Apr 16, 2019
Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Fatigue Trial in Korea, Republic of, United States
Unknown status
- Endometrial Clear Cell Adenocarcinoma
- +6 more
- 3-Dimensional Conformal Radiation Therapy
- +7 more
-
Birmingham, Alabama
- +539 more
Mar 8, 2019
Fatigue Trial in Houston (blue-wavelength enriched ceiling light, mild exercise)
Completed
- Fatigue
- blue-wavelength enriched ceiling light
- mild exercise
-
Houston, TexasJohnson Space Center
Jan 16, 2019
Fatigue and Symptom Burden in Low-Risk Cancer Patients
Completed
- Fatigue
- +2 more
- Questionnaire
-
Houston, TexasM D Anderson Cancer Center
Oct 18, 2018
Breast Cancer, Fatigue, Gastrointestinal Cancer Trial in Houston (Methylphenidate, Placebo)
Terminated
- Breast Cancer
- +2 more
- Methylphenidate
- Placebo
-
Houston, TexasUT MD Anderson Cancer Center
Dec 8, 2017
Leukemia, Lymphoma, Fatigue Trial in Houston (Food Record, Nutritional Consults)
Completed
- Leukemia
- +2 more
- Food Record
- Nutritional Consults
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 23, 2014
Fatigue in Emergency Center Patients
Terminated
- Advanced Cancer
- +2 more
- Surveys
-
Houston, TexasU.T.M.D. Anderson Cancer Center
Jul 26, 2012
Combined Strength Training and Functional Endurance Exercise
Completed
- Breast Cancer
- Fatigue
- Combined Strength Training and Functional Endurance Exercise
- Questionnaire
-
Houston, TexasU.T. M.D. Anderson Cancer Center
Jul 27, 2012